Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

126 trials with published results (20%)

Research Maturity

490 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.6%

42 terminated out of 641 trials

Success Rate

92.1%

+5.6% vs benchmark

Late-Stage Pipeline

25%

163 trials in Phase 3/4

Results Transparency

26%

126 of 490 completed with results

Key Signals

126 with results92% success42 terminated

Data Visualizations

Phase Distribution

477Total
Not Applicable (112)
Early P 1 (1)
P 1 (106)
P 2 (95)
P 3 (78)
P 4 (85)

Trial Status

Completed490
Terminated42
Unknown39
Withdrawn22
Recruiting21
Not Yet Recruiting14

Trial Success Rate

92.1%

Benchmark: 86.5%

Based on 490 completed trials

Clinical Trials (641)

Showing 20 of 20 trials
NCT04949464Not ApplicableRecruitingPrimary

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

NCT07620652Not Yet RecruitingPrimary

Retrospective/Prospective Pilot Study to Evaluate Efficacy and Safety of Switching to BIC/FTC/TAF in PWH With a Previous Virological Failure Under CAB/RPV LAI

NCT00221754Phase 2CompletedPrimary

Pravastatin and Protease Inhibitors in HIV-infected Patients

NCT05663502Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

NCT06708351Not ApplicableNot Yet RecruitingPrimary

Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial

NCT04514484Phase 1Active Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT07042945Phase 1RecruitingPrimary

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

NCT02140255Phase 1RecruitingPrimary

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

NCT04103593Not ApplicableCompletedPrimary

Functional Interval Training for Veterans Exercising Through Telehealth.

NCT06856174Phase 4RecruitingPrimary

Menopausal HT for Women Living With HIV (HoT)

NCT02797470Phase 1Active Not RecruitingPrimary

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT04929028Phase 2Active Not Recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT06771843Not ApplicableRecruiting

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

NCT05965245Not ApplicableActive Not Recruiting

Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

NCT03707977Phase 1CompletedPrimary

Dual bNAb Treatment in Children

NCT04265950Phase 4Active Not RecruitingPrimary

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial

NCT07552038Not Yet RecruitingPrimary

Dental Management of Patients With HIV in Pays de la Loire

NCT01038401Not ApplicableCompletedPrimary

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

NCT01952587Not ApplicableCompletedPrimary

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study

NCT01207986Not ApplicableCompletedPrimary

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

Scroll to load more

Research Network

Activity Timeline